S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Home › EFX › Research report
← EFX page
XStocksXray
Research report · 16 October 2026

Equifax Inc (EFX)

Industrials · Research & Consulting Services · US stock · price as of 16 Oct 2026

Key indicators

Price$161.25
52-week range$137.01 – $236.24
Market cap$19.2B
P/E (trailing)28.5×
EV / EBITDA12.9×
Free-cash-flow yield5.7%
Dividend yield1.4%
Revenue (last 12 months)$6.4B
Revenue growth (3y a year)5.8%
Operating margin17.9%
Return on invested capital8.8%
Net debt / EBITDA2.8×

Fair value

Blended fair value$151.74 range $144 – $161
Versus priceFair−6% to fair value
Peer multiples$165.68
Fundamentals-adjusted multiple$172.36
10-year DCF (market-scaled)$117.19
Earnings power value (floor, not blended)$51.05
Model uncertaintyMedium

X-Ray Score

51/ 100 · High confidence · ahead of 49% of sector peers
Valuation58
Growth65
Profitability48
Financial health25
Dividends61

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

127173219265311Fair value $1522021-102023-012024-042025-072026-10

Executive summary

Equifax is a credit reporting and data analytics company. It collects and organises information on consumers and businesses, and it sells credit reports, scores, identity verification, fraud prevention and employment and income verification services to lenders, employers and government agencies. Revenue comes from data and analytics fees, often tied to transaction volumes such as loan applications, so activity in mortgage and consumer credit markets matters.

Trailing twelve-month revenue stands at $6.4 billion, while revenue grew by 5.8% a year over the past three years. Return on invested capital is 9%, alongside an operating margin of 17.9%. Net debt is 2.8 times EBITDA. The company pays a dividend, and the yield is 1.4%.

StocksXray gives Equifax Inc an X-Ray Score of 51 out of 100 (high confidence), ahead of 49% of the S&P 500 stocks in its sector. Its strongest lens is growth (65) and its weakest is financial health (25).

Our fair value blend is $151.74 (range $143.69 to $160.64). At $161.25 the stock trades 6% above that blend, so the label is "Fair" with medium model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Equifax Inc (EFX)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$281.78$188.53$241.67$250.55$215.03$161.25
Market cap$34.8B$23.2B$29.9B$31.3B$26.7B$19.2B
P/E46.8×33.4×54.9×51.8×40.4×28.5×
EV / revenue8.1×5.6×6.7×6.4×5.2×3.8×
EV / EBITDA24.5×17.7×22.8×21.0×17.4×13.0×
Price / free cash flow40.2×175.3×58.1×38.5×23.5×17.4×
Free-cash-flow yield2.5%0.6%1.7%2.6%4.3%5.7%
Price / book9.7×5.9×6.6×6.5×5.8×4.4×
Dividend yield0.55%0.83%0.65%0.62%0.88%1.35%

Fundamentals checklist ● 4 Good · ● 6 Average · ● 5 Bad · each check graded against the sector

Cash quality

Earnings backed by cash−7.7%Good
Free-cash-flow yield5.7%Good

Risk models

Altman Z score2.5×Average
Piotroski F-Score6 of 9Average

Growth

EPS growth (3y)−2.0%Bad
Free-cash-flow growth (3y)104.5%Good
Revenue growth (3y)5.8%Average
Growth consistency100%Good

Balance sheet

Current ratio0.6×Bad
Net debt / EBITDA2.8×Bad
Interest cover5.2×Bad

Valuation

Fair value vs price0.9×Average
EBIT / EV yield4.7%Average

Profitability

Return on invested capital8.8%Bad
Operating margin17.9%Average
stocksxray.com · page 2
XStocksXray
Equifax Inc (EFX)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue4,9245,1225,2655,6816,0756,445
Gross profit––––––
Operating income1,1381,0569341,0421,0951,150
Net income744696545604660691
Diluted EPS ($)6.025.654.404.845.325.66
Free cash flow8661335168131,1341,105
Gross margin––––––
Operating margin23.1%20.6%17.7%18.3%18.0%17.9%
Net margin15.1%13.6%10.4%10.6%10.9%10.7%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets11,04111,54812,28011,75911,86411,982
Cash225285217170181170
Total debt5,2955,7875,7115,0115,0935,467
Equity3,5843,9574,5344,7974,6044,380
Dividend per share ($)1.561.561.561.561.892.12

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%8%15%23%FY21FY22FY23FY24FY25

Latest quarters

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ($M)1,4421,5371,5451,5511,6491,700
Growth vs a year earlier+3.8%+7.4%+7.2%+9.2%+14.3%+10.6%
Net income ($M)133191160176172184
Diluted EPS ($)1.061.531.29–1.421.54
stocksxray.com · page 3
XStocksXray
Equifax Inc (EFX)

Peers in Research & Consulting Services

CompanyX-Ray
EFX · Equifax Inc51
VRSK · Verisk Analytics, Inc.59

Market Compass outlook for Industrials: Neutral (45/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+10.6%
1 month+0.0%
3 months−10.2%
6 months−17.3%
1 year−29.0%
3 years−11.4%
5 years−35.1%

Technical summary

DailyBearish6 bullish · 1 neutral · 9 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish
50-day / 200-day average$167.41 / $178.10
52-week low / high$137.01 / $236.24
Classic pivot, support and resistanceS2 156.73 · S1 158.99 · P – · R1 163.92 · R2 166.59

Recent dividends

Ex-dividend dateAmount per share
31 Aug 2026$0.5600
22 May 2026$0.5600
9 Mar 2026$0.5600
24 Nov 2025$0.5000
2 Sep 2025$0.5000
23 May 2025$0.5000
stocksxray.com · page 4
XStocksXray
Equifax Inc (EFX)

Strengths

  • Free-cash-flow yield of 5.7% is ahead of 78% of its sector peers.
  • Piotroski F-Score of 6 out of 9: most of the nine accounting health tests pass.
  • Has raised its dividend for 7 years in a row.

Risks and weak spots

  • EPS growth (3y) is weak against Industrials peers (−2.0%).
  • Current ratio is weak against Industrials peers (0.6×).
  • Net debt / EBITDA is weak against Industrials peers (2.8×).
  • Interest cover is weak against Industrials peers (5.2×).
  • Return on invested capital is weak against Industrials peers (8.8%).

Latest SEC filings

DateFormItems
29 Jul 20268-K8.01,9.01
21 Jul 202610-Q
21 Jul 20268-K2.02,9.01
16 Jun 20268-K5.03,9.01
13 May 20268-K5.07
24 Apr 20268-K1.01,2.03,9.01
21 Apr 202610-Q
21 Apr 20268-K2.02,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 19 Oct 2026